Source and Physiological Significance of Plasma 3,4‐Dihydroxyphenylalanine in the Rat

Authors:

Abstract
To elucidate the source and physiological significance of plasma 3,4‐dihydroxyphenylalanine, the immediate product of the rate‐limiting step in catecholamine biosynthesis, plasma 3,4‐dihydroxyphenylalanine was quantified in conscious rats after administration of reserpine, desipramine, clorgyline, or forskolin, treatments that affect tyrosine hydroxylase activity. Plasma 3,4‐dihydroxyphenylalanine was also examined during infusions of norepinephrine with or without clorgyline, reserpine, or desipramine pretreatment. After reserpine, the plasma 3,4‐dihydroxyphenylalanine level decreased by 22% and then increased by 40%, a result consistent with modulation of tyrosine hydroxylase activity first by an increased axoplasmic norepinephrine content and then by depletion of norepinephrine stores. After desipramine, the plasma 3,4‐dihydroxyphenylalanine level decreased by 20%, reflecting the depressant effect of neuronal uptake blockade on norepinephrine turnover. Forskolin increased the plasma 3,4‐dihydroxyphenylalanine level by 30%, consistent with activation of tyrosine hydroxylase by cyclic AMP‐dependent phosphorylation. Acute administration of clorgyline was without effect on the plasma 3,4‐dihydroxyphenylalanine level. Norepinephrine infusions decreased the plasma 3,4‐dihydroxyphenylalanine concentration, as expected from end‐product inhibition of tyrosine hydroxylase. Pretreatment with desipramine prevented the norepinephrine‐induced decrease in plasma dihydroxyphenylalanine content, indicating that inhibition of tyrosine hydroxylase required neuronal uptake of norepinephrine. Both reserpine and clorgyline augmented the norepinephrine‐induced decrease in plasma 3,4‐dihydroxyphenylalanine level, suggesting that retention of norepinephrine in the axoplasm—due to inhibition of norepinephrine sequestration into storage vesicles or catabo‐lism—caused further inhibition of tyrosine hydroxylase. Changes in plasma 3,4‐dihydroxyphenylalanine concentration during norepinephrine infusions were negatively correlated with those in plasma 3,4‐dihydroxyphenylglycol level, a finding consistent with modulation of tyrosine hydroxylase activity by axoplasmic norepinephrine. In reserpinized animals, clorgyline and norepinephrine infusion together decreased the plasma 3,4‐dihydroxyphenylalanine content by 50%, a result demonstrating that hydroxylation of tyrosine was depressed by at least half. The results indicate that quantification of plasma 3,4‐dihydroxyphenylalanine can provide a simple and direct approach for examination of the rate‐limiting step in catecholamine biosynthesis.

This publication has 29 references indexed in Scilit: